Prism MarketView

January 04, 2024 at 10:02 am

ProMIS Neurosciences Replaces CEO, Gail Farfel

Biotechnology company, ProMIS Neurosciences Inc. (Nasdaq: PMN), has announced it will replace its current Chief Executive Officer, Gail Farfel with Neil Warma, a highly-qualified biotechnology… [Read More]

January 04, 2024 at 10:00 am

ABVC BioPharma Shares Soar After $460M Payday

ABVC BioPharma, Inc. (Nasdaq: ABVC) and its subsidiary BioLite, Inc have received an aggregate of 46 million shares from AiBtl BioPharma Inc. as its first… [Read More]

January 03, 2024 at 2:07 pm

Voyager Therapeutics Receives $100M Upfront in Novartis Collaboration

Voyager Therapeutics (Nasdaq: VYGR) has entered a strategic collaboration and license agreement with Novartis Pharma AG, a subsidiary of Novartis AG (NYSE: NVS) to advance… [Read More]

January 03, 2024 at 1:58 pm

CollPlant Biotechnologies Evaluates 3D-Bioprinted Regenerative Breast Implants in Preclinical Study

Regenerative and aesthetics medicine company, CollPlant Biotechnologies (Nasdaq: CLGN) has initiated a preclinical trial to evaluate commercial-size, 3D-bioprinted, regenerative breast implants. There is currently no… [Read More]

January 02, 2024 at 2:28 pm

Bright Minds Announces Positive Topline Data for Potential Psychosis and Addiction Treatment

Bright Minds Biosciences Inc. (Nasdaq: DRUG) has announced the successful completion of its three-part Phase 1 study of BMB-101. The study, conducted in Adelaide, Australia,… [Read More]

December 29, 2023 at 10:18 am

Codexis Partners with Nestlé Health Science in Promising EPI Treatment Deal Worth Up to $45M

Codexis, Inc. (NASDAQ: CDXS) has signed a purchase agreement with Nestlé Health Science for CDX-7108, a therapy aimed at treating exocrine pancreatic insufficiency (EPI). The… [Read More]

December 20, 2023 at 2:41 pm

PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success

Clinical-stage biotechnology company, Lipella Pharmaceuticals (Nasdaq: LIPO) is celebrating a year of strategic accomplishments on its first anniversary as a public company. Lipella is advancing… [Read More]

December 20, 2023 at 11:17 am

Structure Therapeutics Falls 41% on GLP-1 Drug Update

Structure Therapeutics Inc. (Nasdaq: GPCR) has provided a program update for its highly selective oral GLP-1 receptor agonist, GSBR-1290. The drug demonstrated clinically meaningful activity… [Read More]

December 19, 2023 at 10:27 am

FDA Approval for Panbela Therapeutics Pediatric Cancer Drug; Shares Jump 120%

Panbela Therapeutics, Inc. (Nasdaq: PBLA) has announced that US WorldMeds®1 (USWM) has received FDA approval of its New Drug Application (NDA) for the use of… [Read More]

December 19, 2023 at 10:24 am

NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has been granted FDA clearance for its Investigational New Drug Application (IND) for NRX-101 for the treatment of complicated Urinary… [Read More]

December 18, 2023 at 8:56 am

Organon Partners with Lilly to Commercialize Migraine Medications in Europe

Global healthcare company, Organon (NYSE: OGN), has entered an agreement with Eli Lilly and Company (NYSE: LLY) to become the sole distributor and promoter for… [Read More]

December 18, 2023 at 8:47 am

Biotech Breakfast – Verrica Pharmaceuticals Soars, Healthcare Equities Dip & Cancer Vaccine Advances

Healthcare equities finished mostly lower following an uneventful day on Friday. Healthcare fell by (0.85%) versus the S&P 500 which was down (0.01%). It was… [Read More]

Tag: BIO TECH